Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$22.2 million.

  • Upstream Bio's Cash from Operations fell 5928.95% to -$22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.3 million, marking a year-over-year decrease of 11960.84%. This contributed to the annual value of -$59.2 million for FY2024, which is 5601.96% down from last year.
  • Latest data reveals that Upstream Bio reported Cash from Operations of -$22.2 million as of Q3 2025, which was down 5928.95% from -$39.2 million recorded in Q2 2025.
  • Upstream Bio's 5-year Cash from Operations high stood at -$8.0 million for Q2 2024, and its period low was -$41.2 million during Q1 2025.
  • In the last 3 years, Upstream Bio's Cash from Operations had a median value of -$18.6 million in 2024 and averaged -$22.2 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 2173.81% in 2024, then plummeted by 38829.02% in 2025.
  • Over the past 3 years, Upstream Bio's Cash from Operations (Quarter) stood at -$16.1 million in 2023, then fell by 21.74% to -$19.6 million in 2024, then dropped by 13.4% to -$22.2 million in 2025.
  • Its last three reported values are -$22.2 million in Q3 2025, -$39.2 million for Q2 2025, and -$41.2 million during Q1 2025.